Differential effects of therapeutic complement inhibitors on serum bactericidal activity against non-groupable meningococcal isolates recovered from patients treated with eculizumab

• Dan M. Granoff,
• Howard Kim,
• Nadav Topaz,
• Jessica MacNeil,
• Xin Wang,
• Lucy A. McNamara

Affiliations

Dan M. Granoff

Center for Immunobiology and Vaccine Development, UCSF Benioff Children’s Hospital Oakland, Oakland, CA

Howard Kim

Center for Immunobiology and Vaccine Development, UCSF Benioff Children’s Hospital Oakland, Oakland, CA

Nadav Topaz

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA

Jessica MacNeil

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA

Xin Wang

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA

Lucy A. McNamara

Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA